Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Miller

Showing results (51-60 of 654) with videos related to

Pageof 66
Sort By:
Current Cardiology Reports|August 10, 2020
Icosapent Ethyl: Niche Drug or for the Masses?Najdat Bazarbashi, Michael Miller
Regional Anesthesia and Pain Medicine|March 2, 2020
Response to: 'Posterior quadratus lumborum block in the combat environment' by Dhanjal <i>et al</i>Robert Burch, Michael Miller
Expert Review of Cardiovascular Therapy|April 2, 2020
Icosapent ethyl: drug profile and evidence of reduced residual cardiovascular risk in patients with statin-managed LDL-C cholesterolNajdat Bazarbashi, Michael Miller
Current Cardiology Reports|July 11, 2021
A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021Tahreem Iqbal, Michael Miller
Current Opinion in Endocrinology, Diabetes, and Obesity|March 5, 2008
Low high-density lipoprotein cholesterol: an important consideration in coronary heart disease risk assessmentFarhan Majeed, Michael Miller
Current Cardiology Reports|October 28, 2008
The role of triglycerides in cardiovascular riskPuneet Gandotra, Michael Miller
Future Cardiology|October 7, 2009
Can intense exercise contribute to cardiovascular disease?Farhan Majeed, Michael Miller
Operative Neurosurgery (Hagerstown, Md.)|December 30, 2020
Middle Cerebral Artery Aneurysm Clipping With Immersive 360° Virtual Reality Model: 2-Dimensional Operative VideoAbilash Haridas, Michael Miller
The Medical Clinics of North America|March 1, 2022
Triglycerides: How to Manage Patients with Elevated Triglycerides and When to Refer?Najdat Bazarbashi, Michael Miller
Clinical Cardiology|February 14, 2009
Cholesterol goals: moving from numbers to treatmentRobert A Vogel, Michael Miller
Pageof 66

Showing results (51-60 of 654) with videos related to

Sort By:
Pageof 66
Current Cardiology Reports|August 10, 2020
Icosapent Ethyl: Niche Drug or for the Masses?Najdat Bazarbashi, Michael Miller
Regional Anesthesia and Pain Medicine|March 2, 2020
Response to: 'Posterior quadratus lumborum block in the combat environment' by Dhanjal <i>et al</i>Robert Burch, Michael Miller
Expert Review of Cardiovascular Therapy|April 2, 2020
Icosapent ethyl: drug profile and evidence of reduced residual cardiovascular risk in patients with statin-managed LDL-C cholesterolNajdat Bazarbashi, Michael Miller
Current Cardiology Reports|July 11, 2021
A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021Tahreem Iqbal, Michael Miller
Current Opinion in Endocrinology, Diabetes, and Obesity|March 5, 2008
Low high-density lipoprotein cholesterol: an important consideration in coronary heart disease risk assessmentFarhan Majeed, Michael Miller
Current Cardiology Reports|October 28, 2008
The role of triglycerides in cardiovascular riskPuneet Gandotra, Michael Miller
Future Cardiology|October 7, 2009
Can intense exercise contribute to cardiovascular disease?Farhan Majeed, Michael Miller
Operative Neurosurgery (Hagerstown, Md.)|December 30, 2020
Middle Cerebral Artery Aneurysm Clipping With Immersive 360° Virtual Reality Model: 2-Dimensional Operative VideoAbilash Haridas, Michael Miller
The Medical Clinics of North America|March 1, 2022
Triglycerides: How to Manage Patients with Elevated Triglycerides and When to Refer?Najdat Bazarbashi, Michael Miller
Clinical Cardiology|February 14, 2009
Cholesterol goals: moving from numbers to treatmentRobert A Vogel, Michael Miller
Pageof 66